High‐resolution serum proteome trajectories in COVID‐19 reveal patient‐specific seroconversion

A deeper understanding of COVID‐19 on human molecular pathophysiology is urgently needed as a foundation for the discovery of new biomarkers and therapeutic targets. Here we applied mass spectrometry (MS)‐based proteomics to measure serum proteomes of COVID‐19 patients and symptomatic, but PCR‐negat...

Descripción completa

Detalles Bibliográficos
Autores principales: Geyer, Philipp E, Arend, Florian M, Doll, Sophia, Louiset, Marie‐Luise, Virreira Winter, Sebastian, Müller‐Reif, Johannes B, Torun, Furkan M, Weigand, Michael, Eichhorn, Peter, Bruegel, Mathias, Strauss, Maximilian T, Holdt, Lesca M, Mann, Matthias, Teupser, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8687121/
https://www.ncbi.nlm.nih.gov/pubmed/34232570
http://dx.doi.org/10.15252/emmm.202114167

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8687121/
https://www.ncbi.nlm.nih.gov/pubmed/34232570
http://dx.doi.org/10.15252/emmm.202114167

Ejemplares similares